- Home
- RCKT vs CADL Comparison
RCKT vs CADL Comparison
Compare RCKT & CADL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- RCKT
- CADL
- Stock Information
- Founded
- RCKT 1999
- CADL 1999
- Country
- RCKT United States
- CADL United States
- Employees
- RCKT N/A
- CADL N/A
- Industry
- RCKT Biotechnology: Pharmaceutical Preparations
- CADL Biotechnology: Pharmaceutical Preparations
- Sector
- RCKT Health Care
- CADL Health Care
- Exchange
- RCKT Nasdaq
- CADL Nasdaq
- Market Cap
- RCKT 328.6M
- CADL 339.8M
- IPO Year
- RCKT N/A
- CADL 2021
- Fundamental
- Price
- RCKT $3.88
- CADL $5.45
- Analyst Decision
- RCKT Buy
- CADL Strong Buy
- Analyst Count
- RCKT 13
- CADL 6
- Target Price
- RCKT $12.88
- CADL $20.33
- AVG Volume (30 Days)
- RCKT 3.1M
- CADL 848.8K
- Earning Date
- RCKT 11-03-2025
- CADL 11-13-2025
- Dividend Yield
- RCKT N/A
- CADL N/A
- EPS Growth
- RCKT N/A
- CADL N/A
- EPS
- RCKT N/A
- CADL N/A
- Revenue
- RCKT N/A
- CADL N/A
- Revenue This Year
- RCKT N/A
- CADL N/A
- Revenue Next Year
- RCKT $3,592.75
- CADL N/A
- P/E Ratio
- RCKT N/A
- CADL N/A
- Revenue Growth
- RCKT N/A
- CADL N/A
- 52 Week Low
- RCKT $2.19
- CADL $3.79
- 52 Week High
- RCKT $18.17
- CADL $14.60
- Technical
- Relative Strength Index (RSI)
- RCKT 56.54
- CADL 50.32
- Support Level
- RCKT $3.67
- CADL $5.11
- Resistance Level
- RCKT $4.06
- CADL $5.60
- Average True Range (ATR)
- RCKT 0.27
- CADL 0.36
- MACD
- RCKT 0.00
- CADL -0.05
- Stochastic Oscillator
- RCKT 43.27
- CADL 30.87
About RCKT Rocket Pharmaceuticals Inc.
Rocket Pharmaceuticals Inc is a late-stage biopharmaceutical company. It is focused on the development of gene therapies for rare and devastating pediatric diseases. The pipeline products of the company include RP-A501 for Danaon Disease, RP-L102 for Fanconi Anemia, RP-L201 for Leukocyte Adhesion, RP-L301 for Pyruvate Kinase Deficiency, and RP-L401 for Infantile Malignant Osteopetrosis. The Company has one reportable segment related to R&D and commercial readiness of its gene therapies.
About CADL Candel Therapeutics Inc.
Candel Therapeutics Inc is a clinical-stage biopharmaceutical company focused on developing and commercializing viral immunotherapies to help patients fight cancer. The company has established two clinical-stage viral immunotherapy platforms based on novel, genetically modified adenovirus and herpes simplex virus (HSV) constructs, respectively.